Skip to main content
Caplight Logo









TerraNova Bio

TerraNova Bio

Private
Santa Cruz, CaliforniaEnergy & Sustainabilityhttps://terranovabio.tech

Last Round

Grant

Nov 6, 2024

Total Funding Raised

$2,500

Company Overview

TerraNova Bio operates in Energy & Sustainability and is based in Santa Cruz, California. Its latest recorded funding round was a Grant round in November 2024.

TerraNova Bio is a biotechnology company that engineers fungi to break down industrial plastic waste into non-toxic bioproducts.

Sector

Energy & Sustainability

Verticals

Biotechnology, Waste Management, Circular Economy, Sustainable Materials

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

TerraNova Bio Comparables

Compare TerraNova Bio with similar companies based on industry and business-model similarity.

TerraNova Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Breaking
84%
Mycocycle
81%
Rhea's Factory
70%
Book a demo to see all comparables

For institutional investors. Book with your work email.

TerraNova Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantNov 6, 2024
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

TerraNova Bio Investors

Notable investors and investment history

TerraNova Bio investors
InvestorRounds
Santa Cruz WorksGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 6, 2024

    $2.5K grant from Santa Cruz Works

Book a demo to see all signals

For institutional investors. Book with your work email.

TerraNova Bio Filings

Explore SEC and related filing metadata, where available.

TerraNova Bio filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about TerraNova Bio's valuation, stock price, and market status.

Is TerraNova Bio a public or private company?

TerraNova Bio is a private company.

What is the current stock price of TerraNova Bio?

TerraNova Bio is a private company, so its shares have no public market price. Caplight tracks TerraNova Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is TerraNova Bio worth (valuation)?

Valuation information for TerraNova Bio is not publicly available.

Can I buy TerraNova Bio stock?

TerraNova Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was TerraNova Bio's last funding round?

TerraNova Bio's most recent funding round was Grant on November 6, 2024.

Who are the main investors in TerraNova Bio?

Key investors in TerraNova Bio include Santa Cruz Works.

Will TerraNova Bio IPO soon?

No public IPO plans have been announced for TerraNova Bio.

How can I track TerraNova Bio secondary market activity?

Caplight tracks bids, offers, and trades in TerraNova Bio's shares on secondary markets.

Firmographic Details

HeadquartersSanta Cruz, California
Year Founded2025
Last FundingNov 6, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?